According to a Research Report Published by Decisions Advisors and Consulting, The Global Molecular Biology Enzymes, Kits, and Reagents Market Size was worth around USD 15.75 Billion in 2024 and is predicted to Grow to around USD 41.23 Billion by 2035 with a compound annual growth rate (CAGR) of 9.14% from 2025 to 2035. The demand for molecular biology enzymes, reagents, and kits to support diagnostics, biomarker identification, and treatment development is being driven by the rising frequency of infectious and chronic diseases as well as the expansion of biopharmaceutical R&D activities. In high-throughput research and clinical laboratories, the use of automation-compatible and contamination-free reagents is opening up new product development prospects.